Cover Image
市場調查報告書

防打鼾裝置及手術的全球市場分析:各類型 (口內止鼾牙套,鼻腔擴張藥,下巴托,位置管理,持舌器,正壓呼吸輔助器),各地區,市場區隔預測

Anti-Snoring Devices And Snoring Surgery Market By Device Type (Oral, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, Expiratory Positive Airway Pressure), By Surgical Procedure, By Region And Segment Forecast To 2024

出版商 Grand View Research, Inc. 商品編碼 368022
出版日期 內容資訊 英文 91 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
防打鼾裝置及手術的全球市場分析:各類型 (口內止鼾牙套,鼻腔擴張藥,下巴托,位置管理,持舌器,正壓呼吸輔助器),各地區,市場區隔預測 Anti-Snoring Devices And Snoring Surgery Market By Device Type (Oral, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, Expiratory Positive Airway Pressure), By Surgical Procedure, By Region And Segment Forecast To 2024
出版日期: 2016年07月31日 內容資訊: 英文 91 Pages
簡介

本報告提供全球防打鼾裝置及手術市場相關調查,彙整產業預測,以及各類型,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 產業趨勢分析
  • 波特五力分析模式
  • 企業的市場佔有率分析
  • 優先的主要機會

第4章 各類型市場

  • 市場佔有率
  • 口內止鼾牙套/護齒
  • 鼻腔擴張藥
  • 抗菌劑
  • 位置管理設備
  • 下巴托
  • 持舌器
  • 正壓呼吸輔助器

第5章 各類型預測

  • 手術市場佔有率
  • 懸壅垂顎咽整形術
  • 雷射懸壅垂顎咽整形術
  • 射頻消融術
  • 打鼾術
  • 注射性打鼾成型術
  • Palatal stiffening procedures
  • 其他

第6章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

第7章 競爭環境

  • Apnea Sciences Corporation
  • The Pure Sleep Company
  • SomnoMed Ltd.
  • Airway Management, Inc.
  • Theravent, Inc.
  • Tomed Dr. Toussaint Gmbh
  • Glaxosmithkline Plc
  • Meditas Ltd.

圖表

目錄

Global anti-snoring devices and snoring surgery market is expected to reach USD 1.84 billion by 2024, according to a new report by Grand View Research, Inc. The anti-snoring devices and snoring surgery market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing awareness levels about the ill effects of snoring, rising elderly and obese population, the presence of an unexploited consumer base, and the increasing consumption of alcohol and cigarettes. However, factors such as the cost prohibitive nature of the products, limited efficacy of the presently available treatments, and the presence of an unpropitious reimbursement scenario are likely to hinder the growth of the market.

The market is segmented into anti-snoring devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabilizing devices, and expiratory positive airway pressure therapy devices. The surgery segment includes uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. North America and Europe are the major shareholders of this industry due mainly to the increasing awareness associated with available treatment options and the eventual rise in popularity and adoption of these products. The Asia Pacific region is expected to witness high growth as a consequence of the untapped population base characterized with a snoring condition, higher levels of awareness regarding the effects of snoring, and the presence of well-established players in the sector.

Further key findings from the study suggest:

North America is estimated to lead the industry with the largest market share in 2015.This growth is attributed to the rapidly increasing popularity and the resultant high market penetration of such treatment devices. Asia Pacific is expected to exhibit the highest growth rate owing to the large untreated population and the rising awareness levels with regard to treatment options and the notorious health consequences associated with this condition.

In surgery, somnoplasty is estimated to be the fastest growing segment due largely to factors, such as low cost, reduced surgical trauma, less invasive, and chances of fewer complications in comparison to the traditional surgery procedures

The anti-snoring devices and snoring surgery market comprises several local as well as global players. Some key market players include Tomed Dr. Toussaint GmbH, Apnea Sciences Corporation, and Meditas Ltd., among others. The companies have adopted several organic and inorganic strategies in order to gain prominence in this sector. A few of these strategies include geographic expansion, new product launches, new product development, partnerships, collaborations, and mergers and acquisitions, among others. For instance, in March 2015, Meditas Ltd. launched nasal dilators for uninterrupted flow of air.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Anti-snoring Devices and Snoring Surgery Market - Industry Summary and Key Buying Criteria, 2013 - 2024

Chapter 3. Anti-snoring Devices and Snoring Surgery: Market Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2013-2024
  • 3.3. Anti-snoring devices and snoring surgery market: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing obese and geriatric population
      • 3.3.1.2. Rising awareness of the ill effects of snoring and benefits of the treatment
      • 3.3.1.3. Technological advancements in anti-snoring devices
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost of custom-made oral appliances
      • 3.3.2.2. Lack of scientific validation and poor efficacy of anti snoring devices available in the market
  • 3.4. Anti-snoring Devices and Snoring Surgery Market: Industry trend analysis
  • 3.5. Anti-snoring Devices and Snoring Surgery Market: PESTEL Analysis
  • 3.6. Anti-snoring Devices and Snoring Surgery Market Industry analysis - Porter's Five Forces Model
  • 3.7. Anti-snoring Devices and Snoring Surgery Market: Company Market Share Analysis (%), 2015
  • 3.8. Key opportunities prioritized

Chapter 4. Anti-snoring Devices Market, Type Outlook

  • 4.1. Anti-snoring Devices and Snoring Surgery Market Share (%) Analysis, by Type, 2016 & 2024
  • 4.2. Oral appliances/mouthpieces
    • 4.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 4.3. Nasal devices
    • 4.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 4.4. Position control devices
    • 4.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 4.5. Chin straps
    • 4.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 4.6. Tongue stabilizing devices
    • 4.6.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 4.7. Expiratory Positive Airway Pressure (EPAP) therapy devices
    • 4.7.1. Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 5. Anti-snoring Surgery Procedures Market, Type Outlook

  • 5.1. Anti-snoring Devices Surgery Procedures Market Share (%) Analysis, by Type, 2016 & 2024
  • 5.2. Uvulopalatopharyngoplasty (UPPP)
    • 5.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.3. Laser-assisted Uvulopalatoplasty (LAUP)
    • 5.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.4. Radiofrequency ablation (Somnoplasty)
    • 5.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.5. Pillar procedure
    • 5.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.6. Injection snoreplasty/sclerotherapy
    • 5.6.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.7. Palatal stiffening procedures
    • 5.7.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.8. Other anti-snoring surgical procedures
    • 5.8.1. Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 6. Anti-snoring Devices and Snoring Surgery Market Regional Outlook

  • 6.1. Anti-snoring Devices and Snoring Surgery Market Share (%) Analysis, by Region, 2016 & 2024
    • 6.1.1. North America
    • 6.1.2. U.S.
      • 6.1.2.1. U.S. Anti-snoring Devices market, by type, 2013 - 2024 (USD Million)
      • 6.1.2.2. U.S. Anti-snoring Surgery procedures market, by type, 2013 - 2024 (USD Million)
    • 6.1.3. Canada
      • 6.1.3.1. Canada anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.1.3.2. Canada anti-snoring surgery procedures market, by type, 2013 - 2024 (USD Million)
  • 6.2. Europe
    • 6.2.1. Germany
      • 6.2.1.1. Germany anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.2.1.2. Germany anti-snoring surgery procedures market, by type, 2013 - 2024 (USD Million)
    • 6.2.2. UK
      • 6.2.2.1. UK anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.2.2.2. UK anti-snoring Surgery procedures market, by type, 2013 - 2024 (USD Million)
  • 6.3. Asia Pacific
    • 6.3.1. India
      • 6.3.1.1. India anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.3.1.2. India anti-snoring surgery procedures market, by type, 2013 - 2024 (USD Million)
    • 6.3.2. China
      • 6.3.2.1. China anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.3.2.2. China anti-snoring surgery procedure market, by type, 2013 - 2024 (USD Million)
    • 6.3.3. Japan
      • 6.3.3.1. Japan anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.3.3.2. Japan anti-snoring surgery procedure market, by type, 2013 - 2024 (USD Million)
  • 6.4. MEA
    • 6.4.1. South Africa
      • 6.4.1.1. South Africa anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.4.1.2. South Africa anti-snoring surgery procedure market, by type, 2013 - 2024 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Brazil
      • 6.5.1.1. Brazil anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.5.1.2. Brazil anti-snoring surgery procedure market, by type, 2013 - 2024 (USD Million)
    • 6.5.2. Mexico
      • 6.5.2.1. Mexico anti-snoring devices market, by type, 2013 - 2024 (USD Million)
      • 6.5.2.2. Mexico anti-snoring surgery procedure market, by type, 2013 - 2024 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Apnea Sciences Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. The Pure Sleep Company
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. SomnoMed Ltd.
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. Airway Management, Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. Theravent, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Financial Performance
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Initiatives
  • 7.6. Tomed Dr. Toussaint Gmbh
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. Glaxosmithkline Plc
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. Meditas Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
Back to Top